Effects of tolazoline and yohimbine on xylazine-induced central nervous system depression, bradycardia, and tachypnea in sheep

Abstract

Summary We compared the ability of tolazoline and yohimbine to antagonize xylazine-induced central nervous system depression, bradycardia, and tachypnea in 9 ewes and 5 rams. Once a week for 3 weeks, each sheep received one iv treatment of 0.4 mg xylazine/kg, 0.4 mg xylazine/kg followed in 10 minutes by 2 mg tolazoline/kg, or 0.4 mg xylazine/kg followed in 10 minutes by 0.2 mg yohimbine/kg. The order of the 3 treatments in each sheep was randomized. Xylazine alone caused recumbency for 41.0 ± 3.7 minutes (mean ± sem ). Tolazoline and yohimbine shortened the xylazine-induced recumbency to 12.1 ± 0.9 minutes and 18.1 ± 1.5 minutes, respectively. Sheep given xylazine alone had head droop for 34.0 ± 5.4 minutes after rising. Head drooping of sheep given tolazoline or yohimbine was reduced to 10.1 ± 1.7 minutes and 14.2 ± 1.7 minutes, respectively. Both tolazoline and yohimbine reversed the bradycardia and tachypnea that followed xylazine administration. No statistical differences in the rate and magnitude of the reversal were observed between the 2 drugs.